99% Slim Peptide Retatrutide Raw Powder Peptide Retatrutide Vial Peptide Reta for Weight Loss Retatrutide Lyophilized Peptide in Vials Retatrutide Tirz Peptide

• Customization: Available
• CAS No.: 2381089-83-2
• Formula: N/a
• Model NO.: tirz
• EINECS: 200-001-8
• Type: Pharmaceutical Intermediates
• Appearance: Powder
• Quality: Refined
• Colour: White
• Content: Standard
• Source: Dry Powder
• Application: Scientific Research
• Property: Protein and Peptide
• Grade: Research Use
• Name: Retatrutide
• CAS: 2381089-83-2
• Note: No Tfa Salt
• From: Authoried Regluar Workshop
• Raw Powder: 1g/Bottle
• Vials: 2mg 5mg 10mg 15mg
• Attention: Research Use Only
• Transport Package: Customized
• Specification: 1G/Bottle 2mg/5mg/10mg per vial
• Trademark: Hoconbio
• Origin: China
• Production Capacity: 50000kits Per Month

Product Description

Retatrutide is a triple hormone (GIP, GLP-1 and glucagon) receptor agonist in development for the treatment of obesity.

Product Name	Retatrutide
CAS NO.	2381089-83-2
Other name	LY3437943 GIPR/GLP-1R
Appearance	White freeze-dried powder
Purity	98% HPLC
Application	Research peptides
Shelf Life	24 Months
Storage	Store at a temperature of 2-8 degrees, protected from light.

1. Treatment of depression and anxiety disorders: Retatrutide has been shown to have antidepressant and anxiolytic effects in preclinical studies, suggesting that it could be a promising treatment option for individuals with these conditions.
2. Prevention of neurodegenerative diseases: Retatrutide has neuroprotective properties that may be useful in preventing or slowing the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
3. Enhancement of cognitive function: Retatrutide has been shown to improve learning and memory in animal studies, suggesting that it could have potential as a cognitive enhancer in humans.
4. Treatment of chronic pain: Retatrutide has been shown to have analgesic effects in preclinical studies, suggesting that it could be a useful treatment option for individuals with chronic pain conditions.
5. Promotion of wound healing: Retatrutide has been shown to accelerate wound healing in animal studies, suggesting that it could have potential as a therapeutic agent for promoting wound healing in humans.